Access
To read this story in full you will need to login or make a payment (see right).
Letters to Nature
Nature 434, 1026-1031 (21 April 2005) | doi:10.1038/nature03439; Received 22 November 2004; Accepted 19 February 2005
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
nature jobs
Sr. Scientific Manager / Chief Scientific Manager - Discovery Bioanalytical Research and Biotransformation
- Syngene International
- Bangalore, Karnataka 560099 India
Copy Editor
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Hypothalamic KATP channels control hepatic glucose production
Alessandro Pocai1, Tony K. T. Lam1, Roger Gutierrez-Juarez1, Silvana Obici1, Gary J. Schwartz1, Joseph Bryan2, Lydia Aguilar-Bryan2 & Luciano Rossetti1
- Departments of Medicine, Neuroscience and Molecular Pharmacology, Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA
- Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
Correspondence to: Luciano Rossetti1 Correspondence and requests for materials should be addressed to L.R. (Email: rossetti@aecom.yu.edu).
Abstract
Obesity is the driving force behind the worldwide increase in the prevalence of type 2 diabetes mellitus1, 2. Hyperglycaemia is a hallmark of diabetes and is largely due to increased hepatic gluconeogenesis3. The medial hypothalamus is a major integrator of nutritional and hormonal signals1, 2, 4, which play pivotal roles not only in the regulation of energy balance but also in the modulation of liver glucose output5, 6. Bidirectional changes in hypothalamic insulin signalling therefore result in parallel changes in both energy balance7, 8, 9, 10 and glucose metabolism5. Here we show that activation of ATP-sensitive potassium (KATP) channels11 in the mediobasal hypothalamus is sufficient to lower blood glucose levels through inhibition of hepatic gluconeogenesis. Finally, the infusion of a KATP blocker within the mediobasal hypothalamus, or the surgical resection of the hepatic branch of the vagus nerve, negates the effects of central insulin and halves the effects of systemic insulin on hepatic glucose production. Consistent with these results, mice lacking the SUR1 subunit of the KATP channel12 are resistant to the inhibitory action of insulin on gluconeogenesis. These findings suggest that activation of hypothalamic KATP channels normally restrains hepatic gluconeogenesis, and that any alteration within this central nervous system/liver circuit can contribute to diabetic hyperglycaemia.
- Departments of Medicine, Neuroscience and Molecular Pharmacology, Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA
- Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
Correspondence to: Luciano Rossetti1 Correspondence and requests for materials should be addressed to L.R. (Email: rossetti@aecom.yu.edu).
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Molecular mechanism of NPF recognition by EH domainsNature Structural Biology Letter (01 Nov 2000)
Hypothalamic sensing of circulating fatty acids is required for glucose homeostasisNature Medicine Article (01 Mar 2005)
Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in ratsNature Neuroscience Article (01 Jun 2002)
See all 13 matches for Research
